| Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome H Schaumburg, J Kaplan, A Windebank, N Vick, S Rasmus, D Pleasure, ... New England Journal of Medicine 309 (8), 445-448, 1983 | 950 | 1983 |
| Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy PJ Dyck, J Daube, P O'brien, A Pineda, PA Low, AJ Windebank, ... New England Journal of Medicine 314 (8), 461-465, 1986 | 828 | 1986 |
| Chemotherapy‐induced neuropathy AJ Windebank, W Grisold Journal of the peripheral nervous system 13 (1), 27-46, 2008 | 810 | 2008 |
| Chemotherapy‐induced peripheral neuropathy: a current review NP Staff, A Grisold, W Grisold, AJ Windebank Annals of neurology 81 (6), 772-781, 2017 | 806 | 2017 |
| Calcium-channel antibodies in the Lambert–Eaton syndrome and other paraneoplastic syndromes VA Lennon, TJ Kryzer, GE Griesmann, PE O'Suilleabhain, AJ Windebank, ... New England Journal of Medicine 332 (22), 1467-1475, 1995 | 700 | 1995 |
| A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery W Daly, L Yao, D Zeugolis, A Windebank, A Pandit Journal of the Royal Society Interface 9 (67), 202-221, 2012 | 679 | 2012 |
| Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment PJ Dyck, PC O'Brien, KF Oviatt, RP Dinapoli, JR Daube, JD Bartleson, ... Annals of Neurology: Official Journal of the American Neurological …, 1982 | 580 | 1982 |
| Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention W Grisold, G Cavaletti, AJ Windebank Neuro-oncology 14 (suppl_4), iv45-iv54, 2012 | 578 | 2012 |
| A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy PJ Dyck, WJ Litchy, KM Kratz, GA Suarez, PA Low, AA Pineda, ... Annals of Neurology: Official Journal of the American Neurological …, 1994 | 571 | 1994 |
| Neurons undergo apoptosis in animal and cell culture models of diabetes JW Russell, KA Sullivan, AJ Windebank, DN Herrmann, EL Feldman Neurobiology of disease 6 (5), 347-363, 1999 | 525 | 1999 |
| Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment PJB Dyck, AJ Windebank Muscle & nerve 25 (4), 477-491, 2002 | 442 | 2002 |
| Designing ideal conduits for peripheral nerve repair GCW De Ruiter, MJA Malessy, MJ Yaszemski, AJ Windebank, RJ Spinner Neurosurgical focus 26 (2), E5, 2009 | 441 | 2009 |
| The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests PJ Dyck, KM Kratz, KA Lehman, JL Karnes, LJ Melton III MD, PC O'brien, ... Neurology 41 (6), 799-799, 1991 | 411 | 1991 |
| Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum–DNA binding LE Ta, L Espeset, J Podratz, AJ Windebank Neurotoxicology 27 (6), 992-1002, 2006 | 405 | 2006 |
| Nonsystemic vasculitic neuropathy PJ Dyck, TJ Benstead, DL Conn, JC Stevens, AJ Windebank, PA Low Brain 110 (4), 843-853, 1987 | 397 | 1987 |
| Multiple-channel scaffolds to promote spinal cord axon regeneration MJ Moore, JA Friedman, EB Lewellyn, SM Mantila, AJ Krych, ... Biomaterials 27 (3), 419-429, 2006 | 384 | 2006 |
| 3, 4-Diaminopyridine in the treatment of Lambert–Eaton myasthenic syndrome KM McEvoy, AJ Windebank, JR Daube, PA Low New England Journal of Medicine 321 (23), 1567-1571, 1989 | 382 | 1989 |
| Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance PJ Dyck, PA Low, AJ Windebank, SS Jaradeh, S Gosselin, P Bourque, ... New England Journal of Medicine 325 (21), 1482-1486, 1991 | 371 | 1991 |
| Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons JL Podratz, AM Knight, LE Ta, NP Staff, JM Gass, K Genelin, A Schlattau, ... Neurobiology of disease 41 (3), 661-668, 2011 | 353 | 2011 |
| Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle. JS Gill, AJ Windebank The Journal of clinical investigation 101 (12), 2842-2850, 1998 | 342 | 1998 |
